[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 World Infectious Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers - France, Germany, Italy, Japan, Spain, UK, USA

June 2015 | 950 pages | ID: 2493A8DCA5AEN
Venture Planning Group

US$ 6,000.00 US$ 7,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 950-page report from VPGMarketResearch provides analysis of the global infectious disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

The report presents:

Estimated numbers of infectious disease testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.

Comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs, and listings of companies developing or marketing new technologies and products.

Major analyzers used for infectious disease testing, including their features and operating characteristics.

Analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.

Strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 950 pages and 34 tables
I. WORLDWIDE BUSINESS ENVIRONMENT

II. WORLDWIDE MARKET STRUCTURE

III. WORLDWIDE MARKET SIZE AND GROWTH

IV. MAJOR INFECTIOUS DISEASE TESTS

1. AIDS
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
6. Babesiosis
  a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
10. Campylobacter
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
12. Chagas Disease
  a. Background
13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
14. Chlamydia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
15. Clostridium Difficile
  a. Background
  b. Diagnostic Tests
  c. Drugs and Vaccines
16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
17. Coxsackieviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines
19. Cryptosporidium Parvum
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
20. Cyclospora Cayetanensis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
21. Cytomegalovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
22. Ebola Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
23. E. Coli
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
24. EchoVirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
25. Encephalitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
26. Enteroviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
27. Epstein-Barr Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
28. Giardia Lamblia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
29. Gonorrhea
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
30. Granuloma Inguinale
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
31. Hantavirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
32. Helicobacter Pylori
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
33. Hepatitis
  a. Background
  b. Hepatitis A
  c. Hepatitis B
  d. Hepatitis C
  e. Vaccines and Drugs
34. Herpes Simplex Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
36. Influenza Viruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
37. Legionella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
38. Lyme Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
40. Malaria
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
41. Measles (Rubeola)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
42. Meningitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
43. Microsporidium
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
44. Mononucleosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
45. Mumps
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
46. Mycoplasma
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
47. Papillomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
48. Parvovirus B19
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
49. Pneumonia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
50. Polyomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
52. Rabies
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
54. RhinoViruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
56. Rubella(MEASLES)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
57. Salmonellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
58. Septicemia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
59. Shigellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
60. Staphylococcus Aureus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
61. Streptococci
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
62. Syphilis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
63. Toxoplasmosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
64. Trichomonas Vaginalis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
65. Tuberculosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
66. Vibrio
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
67. West Nile Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
68. Yersina
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs

V. INSTRUMENTATION REVIEW: LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BIOMERIEUX, ORTH-CLINICAL DIAGNOSTICS, ROCHE, SIEMENS, TOSOH, WALLAC AND OTHER SUPPLIERS

VI. CURRENT AND EMERGING TECHNOLOGIES

1. Molecular Diagnostics
  a. Technology Overview
  b. Amplification Methods
    Polymerase Chain Reaction
      Temperature Cyclers
      PCR Variations
    Immuno-PCR
    QC-PCR
    DAP-PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    Nucleic-Acid Sequence-Based
    Strand Displacement Activation
2. Monoclonal Antibodies
3. Immunoassays
  a. Technological Principle
  b. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Dot Immunobinding Assays
    Capillary Immunoassays
    Particle-Membrane Capture Immunoassays
    Enzyme Amplification
  c. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
  d. Luminescence
    Chemiluminescence
    Bioluminescence
  e. Latex Agglutination
  f. Immunoprecipitation
4. Differential Light Scattering
5. IT
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other

VII. COMPETITIVE PROFILES

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Table 1: Laboratories Performing Infectious Disease Tests by Country
Table 2: Total Infectious Disease Test Volume Forecast by Country
Table 3: Total Infectious Disease Diagnostics Market Forecast by Country


More Publications